Assessment of the 10-year risk of cardiovascular disease among a group of patients on maintenance hemodialysis: A cross-sectional study from Cameroon
JRSM Cardiovascular Disease · 2017-01 · 6
DOI: 10.1177/2048004017705273 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift JRSM Cardiovascular Disease, online erschienen am 18.04.2017. Verfasst von Vicky Jocelyne Ama Moor und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Phisiological Sciences, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Cameroon; Laboratory of …. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
To assess the 10-year risk of cardiovascular disease and potential impacting factors among patients undergoing hemodialysis in Yaoundé, Cameroon.
Design
A cross-sectional study in January 2016.
Setting
Patients were recruited at the dialysis unit of the Yaoundé University Teaching Hospital, Cameroon.
Participants
These were hemodialysis patients aged 20 years and above, dialyzing in the above unit since at least 3 months and volunteering to be enrolled in the study. Main outcome measures The risk of cardiovascular disease was assessed using the Framingham risk score.
Results
We included 44 patients. The risk of cardiovascular disease ranged from less than 1% to more than 30% with a median of 12.3% (interquartile range 4.9–24.4). Twenty hemodialysis patients (45.5%) had a low risk of cardiovascular disease (20%). In multivariable linear regression analysis, duration on dialysis (adjusted β = 0.11; p = 0.003), number of weekly sessions of physical activity (adjusted β = −1.35; p = 0.018), fasting serum glucose levels (adjusted β = 4.22; p = 0.022), serum triglycerides levels (adjusted β = 5.94; p = 0.033), and serum urea levels (adjusted β = −2.08; p = 0.039) were independently impacting our patients’ risk of cardiovascular disease.
Conclusion
Around 55% of our study population presented a moderate or high risk of cardiovascular disease. Duration on dialysis, number of physical activity sessions per week, fasting serum glucose, serum triglycerides, and serum urea levels may impact our hemodialysis patients’ risk of cardiovascular disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry and Phisiological Sciences, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Cameroon; Laboratory of Biochemistry, Yaoundé University Teaching Hospital, Cameroon; School o…
- Department of Public Health, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Cameroon; Sickle Cell Disease Unit, Mother and Child Centre, Chantal Biya Foundation, Cameroon; Department for the Contr…
- School of Health Sciences, Catholic University of Central Africa, Cameroon.
- Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Cameroon; Nephrology Unit, Yaoundé University Teaching Hospital, Cameroon.
Zitieren
APA
Ama Moor, V. J., Nansseu, J. R. N., Azingni, D. B. T., & Kaze, F. F. (2017). Assessment of the 10-year risk of cardiovascular disease among a group of patients on maintenance hemodialysis: A cross-sectional study from Cameroon. JRSM Cardiovascular Disease, 6. https://doi.org/10.1177/2048004017705273
Vancouver
Ama Moor VJ, Nansseu JRN, Azingni DBT, Kaze FF. Assessment of the 10-year risk of cardiovascular disease among a group of patients on maintenance hemodialysis: A cross-sectional study from Cameroon. JRSM Cardiovascular Disease. 2017;6. doi:10.1177/2048004017705273
BibTeX
@article{AmaMoor2017,
author = {Ama Moor, Vicky Jocelyne and Nansseu, Jobert Richie N and Azingni, Dastoresse Bijou T and Kaze, François Folefack},
title = {Assessment of the 10-year risk of cardiovascular disease among a group of patients on maintenance hemodialysis: A cross-sectional study from Cameroon},
journal = {JRSM Cardiovascular Disease},
year = {2017},
volume = {6},
doi = {10.1177/2048004017705273}
}
EUVIMED